NCT01843530View on ClinicalTrials.gov

Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 5, 2018

Study Completion Date

September 30, 2019

Conditions

Acute ACE-induced Angioedema

Interventions

DRUG

Berinert

DRUG

Clemastin

DRUG

Cortisone acetate

DRUG

NaCl

Trial Locations (4)

44787

Kath. Klinikum Bochum, Med. Klinik III, Bochum

81377

Ludwig-Maximilian-Universität, München

81675

Klinikum rechts der Isar, Hals-Nasen-Ohren Klinik, München

89070

Universitätsklinikum Ulm, HNO, Ulm

All Listed Sponsors

lead

Technical University of Munich

OTHER

NCT01843530 - Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema | Biotech Hunter | Biotech Hunter